23: The Unique and Complex World of Combination Products
PharmaLex Talks31 Aug 2023

23: The Unique and Complex World of Combination Products

Combination products offer unique advantages in terms of delivering improved therapeutic outcomes or enhanced patient convenience. Typically, combination products are understood to be a drug-device or biologic-device combination. The regulatory strategy as to which center at the FDA has jurisdiction over product approval depends on their primary mode of action. Listen to the podcast to learn more about combination products and how they are regulated.

Guests’ bio:
John Lockwood is Senior Director, Head of Medical Devices/IVDs, Americas for PharmaLex, where he leverages his more than 28 years of industry experience across quality, regulatory, operations, development, validation, and purchasing. John has worked at both small and large medical device manufacturers and has spent more than a decade in consulting.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(37)

37: Optimizing revenue from mature products

37: Optimizing revenue from mature products

We talk with Paula King, Director, Regulatory Affairs at PharmaLex to better understand the growing trend toward regulatory outsourcing, particularly of the mature product portfolio. Hear how leading ...

18 Juli 20259min

36: What’s happening with eCTD 4.0: New and future developments

36: What’s happening with eCTD 4.0: New and future developments

Join Karl-Heinz Loebel, Director, Regulatory Informatics & Operations at PharmaLex, as he discusses current progress of eCTD 4.0. Ten years after the eCTD 4.0 standard became available for submissions...

18 Juli 202520min

35: Challenges and best practices for managing local pharmacovigilance activities

35: Challenges and best practices for managing local pharmacovigilance activities

In this episode of the PharmaLex Talks Podcast, sits down with Alex Brenchat, Vice President of Local Affiliate Pharmacovigilance Services at PharmaLex, a Cencora company. Together, they explore the c...

9 Maj 202512min

34: Environmental Risk Assessment and its growing importance in the German Pharma Strategy

34: Environmental Risk Assessment and its growing importance in the German Pharma Strategy

Join Angela-Vogt Eisele, Associate Director Scientific Affairs at PharmaLex, a Cencora company for this podcast, where she shares her expertise in Environmental Risk Assessment and its growing importa...

14 Apr 202520min

33: Finding the best approach to manage sterility assurance

33: Finding the best approach to manage sterility assurance

Join PharmaLex's Patrick Nieuwenhuizen for this podcast, where he shares his expertise in sterility assurance and how manufacturers can demonstrate that the finished product is sterile through a holis...

27 Jan 202515min

32: Commercialization Readiness

32: Commercialization Readiness

Pharmaceutical companies new to the EU market must navigate complex and varying commercialization requirements. The podcast highlights key steps for commercialization readiness in Europe, focusing on ...

4 Nov 202413min

31: Key Steps for Site Inspection Readiness

31: Key Steps for Site Inspection Readiness

Louise Uí Fhatharta bio Quality professional with over 20 years’ experience in Microbiology, Quality Control and Quality Assurance roles in the Pharmaceutical Industry including Sterile Fill Finish a...

27 Juni 202417min

30: CSS Overview

30: CSS Overview

A contamination control strategy (CCS) is integral to Annex 1 and is fundamentally about patient safety and identifying and avoiding contamination pathways. Manufacturers are expected to implement a C...

9 Maj 202414min

Populärt inom Politik & nyheter

aftonbladet-krim
svenska-fall
motiv
p3-krim
flashback-forever
aftonbladet-daily
politiken
rss-sanning-konsekvens
rss-krimreportrarna
rss-flodet
rss-vad-fan-hande
rss-frandfors-horna
svd-ledarredaktionen
rss-aftonbladet-krim
grans
krimmagasinet
spar
dagens-eko
rss-krimstad
blenda-2